| pubmed-article:12747279 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:12747279 | lifeskim:mentions | umls-concept:C0040053 | lld:lifeskim |
| pubmed-article:12747279 | lifeskim:mentions | umls-concept:C0003241 | lld:lifeskim |
| pubmed-article:12747279 | lifeskim:mentions | umls-concept:C0085278 | lld:lifeskim |
| pubmed-article:12747279 | lifeskim:mentions | umls-concept:C1704666 | lld:lifeskim |
| pubmed-article:12747279 | lifeskim:mentions | umls-concept:C1517892 | lld:lifeskim |
| pubmed-article:12747279 | lifeskim:mentions | umls-concept:C0208973 | lld:lifeskim |
| pubmed-article:12747279 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:12747279 | pubmed:dateCreated | 2003-5-15 | lld:pubmed |
| pubmed-article:12747279 | pubmed:abstractText | Some studies have previously suggested the involvement of antibodies directed against CD36 (anti-CD36) in the pathogenesis of thrombosis. The aim of this study was to evaluate the prevalence of anti-CD36 in patients with antiphospholipid antibodies (aPL) and its relationship with thrombosis. | lld:pubmed |
| pubmed-article:12747279 | pubmed:language | eng | lld:pubmed |
| pubmed-article:12747279 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12747279 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:12747279 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12747279 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12747279 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:12747279 | pubmed:issn | 0392-856X | lld:pubmed |
| pubmed-article:12747279 | pubmed:author | pubmed-author:CarrerasL OLO | lld:pubmed |
| pubmed-article:12747279 | pubmed:author | pubmed-author:ForastieroR... | lld:pubmed |
| pubmed-article:12747279 | pubmed:author | pubmed-author:MartinuzzoM... | lld:pubmed |
| pubmed-article:12747279 | pubmed:author | pubmed-author:CerratoGG | lld:pubmed |
| pubmed-article:12747279 | pubmed:author | pubmed-author:PelegriYY | lld:pubmed |
| pubmed-article:12747279 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:12747279 | pubmed:volume | 21 | lld:pubmed |
| pubmed-article:12747279 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:12747279 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:12747279 | pubmed:pagination | 221-4 | lld:pubmed |
| pubmed-article:12747279 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:12747279 | pubmed:meshHeading | pubmed-meshheading:12747279... | lld:pubmed |
| pubmed-article:12747279 | pubmed:meshHeading | pubmed-meshheading:12747279... | lld:pubmed |
| pubmed-article:12747279 | pubmed:meshHeading | pubmed-meshheading:12747279... | lld:pubmed |
| pubmed-article:12747279 | pubmed:meshHeading | pubmed-meshheading:12747279... | lld:pubmed |
| pubmed-article:12747279 | pubmed:meshHeading | pubmed-meshheading:12747279... | lld:pubmed |
| pubmed-article:12747279 | pubmed:meshHeading | pubmed-meshheading:12747279... | lld:pubmed |
| pubmed-article:12747279 | pubmed:meshHeading | pubmed-meshheading:12747279... | lld:pubmed |
| pubmed-article:12747279 | pubmed:meshHeading | pubmed-meshheading:12747279... | lld:pubmed |
| pubmed-article:12747279 | pubmed:meshHeading | pubmed-meshheading:12747279... | lld:pubmed |
| pubmed-article:12747279 | pubmed:meshHeading | pubmed-meshheading:12747279... | lld:pubmed |
| pubmed-article:12747279 | pubmed:articleTitle | Link between anti-CD36 antibodies and thrombosis in the antiphospholipid syndrome. | lld:pubmed |
| pubmed-article:12747279 | pubmed:affiliation | Division of Haematology, Favaloro University, Favaloro Foundation, Buenos Aires, Argentina. | lld:pubmed |
| pubmed-article:12747279 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:12747279 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12747279 | lld:pubmed |
